Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity

Neuroscience

Volumn 159, Issue 3, 2009, Pages 1154-1163

  Walczak, J S ^a   Price, T J ^b   Cervero, F ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

CB1 receptors; electrophysiology; ex vivo; immunofluorescence; RT PCR

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; AZ 12646915; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; MESSENGER RNA; PURINERGIC P2X3 RECEPTOR; UNCLASSIFIED DRUG; CANNABINOID; PIPERIDINE DERIVATIVE; PURINERGIC P2 RECEPTOR; PYRAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; ELECTRIC ACTIVITY; EX VIVO STUDY; FEMALE; GENE EXPRESSION; IMMUNOFLUORESCENCE; KIDNEY FUNCTION; MECHANICAL STIMULATION; MOUSE; NERVE FIBER; NONHUMAN; PELVIC NERVE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE; SENSORY NERVE CONDUCTION; UROTHELIUM; ACTION POTENTIAL; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; IN VITRO STUDY; INNERVATION; METABOLISM; MICROELECTRODE; PHYSIOLOGY; SENSORY NERVE CELL; STIMULATION;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; CANNABINOIDS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED C57BL; MICROELECTRODES; NEURONS, AFFERENT; PHYSICAL STIMULATION; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; URINARY BLADDER;

EID: 62549087356     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.01.050     Document Type: Article

References (29)

1. Andersson K.E. Bladder activation: afferent mechanisms. Urology 59 (2002) 43-50
2. Apodaca G., Balestreire E., and Birder L.A. The uroepithelial-associated sensory web. Kidney Int 72 (2007) 1057-1064
3. Bridges D., Rice A.S., Egertova M., Elphick M.R., Winter J., and Michael G.J. Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience 119 (2003) 803-812
4. Cervero F., and Laird J.M. Understanding the signaling and transmission of visceral nociceptive events. J Neurobiol 61 (2004) 45-54
5. Cockayne D.A., Dunn P.M., Zhong Y., Rong W., Hamilton S.G., Knight G.E., Ruan H.Z., Ma B., Yip P., Nunn P., McMahon S.B., Burnstock G., and Ford A.P. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol 567 (2005) 621-639
6. Demuth D.G., and Molleman A. Cannabinoid signalling. Life Sci 78 (2006) 549-563
7. Di Marzo V., Bifulco M., and De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3 (2004) 771-784
8. Dmitrieva N., and Berkley K.J. Contrasting effects of WIN 55,212-2 on motility of the rat bladder and uterus. J Neurosci 22 (2002) 7147-7153
9. Farquhar-Smith W.P., Jaggar S.I., and Rice A.S. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain 97 (2002) 11-21
10. Farquhar-Smith W.P., and Rice A.S. Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology 94 (2001) 507-513 discussion 506A
11. Ferguson D.R., Kennedy I., and Burton T.J. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism?. J Physiol 505 Pt 2 (1997) 503-511
12. Hiragata S., Ogawa T., Hayashi Y., Tyagi P., Seki S., Nishizawa O., de Miguel F., Chancellor M.B., and Yoshimura N. Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. Urology 70 (2007) 202-208
13. Jaggar S.I., Hasnie F.S., Sellaturay S., and Rice A.S. The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76 (1998) 189-199
14. Jaggar S.I., Sellaturay S., and Rice A.S. The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. Neurosci Lett 253 (1998) 123-126
15. Lever I.J., and Rice A.S. Cannabinoids and pain. Handb Exp Pharmacol (2007) 265-306
16. Manzanares J., Julian M., and Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol 4 (2006) 239-257
17. Martin R.S., Luong L.A., Welsh N.J., Eglen R.M., Martin G.R., and MacLennan S.J. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Br J Pharmacol 129 (2000) 1707-1715
18. Merriam F.V., Wang Z.Y., Guerios S.D., and Bjorling D.E. Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats. Neurosci Lett 445 (2008) 130-134
19. Pertwee R.G., and Fernando S.R. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118 (1996) 2053-2058
20. Pertwee R.G., and Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66 (2002) 101-121
21. Rong W., Spyer K.M., and Burnstock G. Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol 541 (2002) 591-600
22. Sengupta J.N., and Gebhart G.F. Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol 72 (1994) 2420-2430
23. Shea V.K., Cai R., Crepps B., Mason J.L., and Perl E.R. Sensory fibers of the pelvic nerve innervating the rat's urinary bladder. J Neurophysiol 84 (2000) 1924-1933
24. Vlaskovska M., Kasakov L., Rong W., Bodin P., Bardini M., Cockayne D.A., Ford A.P., and Burnstock G. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 21 (2001) 5670-5677
25. Walker J.M., and Hohmann A.G. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol (2005) 509-554
26. Wang E.C., Lee J.M., Ruiz W.G., Balestreire E.M., von Bodungen M., Barrick S., Cockayne D.A., Birder L.A., and Apodaca G. ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115 (2005) 2412-2422
27. Yoshimura N. Lower urinary tract symptoms (LUTS) and bladder afferent activity. Neurourol Urodyn 26 (2007) 908-913
28. Yu Y., and de Groat W.C. Sensitization of pelvic afferent nerves in the in vitro rat urinary bladder-pelvic nerve preparation by purinergic agonists and cyclophosphamide pretreatment. Am J Physiol Ren Physiol 294 (2008) F1146-F1156
29. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 6 (1983) 109-110